2.45. Analysis.
Comparison 2 High vs low LCn3 omega‐3 fats (secondary outcomes), Outcome 45 TG, fasting, mmoL/L ‐ LCn3 ‐ subgroup by dose.
Comparison 2 High vs low LCn3 omega‐3 fats (secondary outcomes), Outcome 45 TG, fasting, mmoL/L ‐ LCn3 ‐ subgroup by dose.